Contact
    Start Publications Developability Assessments of Monoclonal Antibody Candidates to ...
    ←  Publication Finder
    KSV NIMA

    Developability Assessments of Monoclonal Antibody Candidates to Minimize Aggregation During Large-Scale Ultrafiltration and Diafiltration (UF-DF) Processing

    Year: 2022

    Journal: J. Pharm. Sci., Volume 111, NOV, page 2998–3008

    Authors: Whitaker, Neal; Pace, Samantha E.; Merritt, Kimberly; Tadros, Madeleine; Khossravi, Mehrnaz; Deshmukh, Smeet; Cheng, Yuan; Joshi, Sangeeta B.; Volkin, David B.; Dhar, Prajnaparamita

    Organizations: BMS

    Keywords: Antibodies; Aggregation; Particles; Diafiltration; Concentration

    Therapeutic proteins are subjected to a variety of stresses during manufacturing, storage or administration, that often lead to undesired protein aggregation and particle formation. Ultrafiltration-diafiltration (UF-DF) processing of monoclonal antibodies (mAbs) is one such manufacturing step that has been shown to result in such physical degradation. In this work, we explore the use of different analytical techniques and lab-scale setups as methodologies to predict and rank-order the aggregation potential of four different mAbs during large-scale UF-DF processing. In the first part of the study, a suite of biophysical techniques was applied to assess differences in their inherent bulk protein properties including conformational and colloidal stability in a PBS buffer. Additionally, the inherent interfacial properties of these mAbs in PBS were measured using a Langmuir trough technique. In the next part of the study, several different scale-down lab models were evaluated including a lab bench-scale UF-DF setup, mechanical stress (shaking/stirring) studies in vials, and application of interfacial dilatational stress using a Langmuir trough to assess protein particle formation in different UF-DF processing buffers. Taken together, our results demonstrate the ability of a Langmuir-trough methodology to accurately predict the mAb instability profile observed during large scale UF-DF processing.(c) 2022 Published by Elsevier Inc. on behalf of American Pharmacists Association.
    View publication